Squamous Cell Carcinoma of the Head and Neck
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And Neck [Phase 2]
A Phase 2 trial comparing MEHD7945A versus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck h…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of talactoferrin in patients with relapsed or refractory non-small cell lung cancer or…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy [Phase 2]
Phase 2 clinical trial comparing concurrent chemoradiotherapy to cetuximab with radiotherapy after neoadjuvant chemotherapy in locally advan…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck [Phase 2]
A Phase 2 study of BIND-014 across urothelial carcinoma, cholangiocarcinoma, cervical cancer, and squamous cell carcinoma of the head and ne…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) [Phase 2]
Phase 2 trial update for PRISM evaluating panitumumab as second-line monotherapy in head and neck cancer; results posted after completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT) [Phase 2]
Phase 2 clinical trial update for squamous cell carcinoma of the head and neck focusing on surgery and radiotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy [Phase 2]
Phase 2 trial update for Sym004 in squamous cell carcinoma of the head and neck after anti-EGFR therapy failure.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer [Phase 2]
Phase 2 study of Proxinium for squamous cell carcinoma of the head and neck was terminated. This update confirms the trial status as TERMINA…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck [Phase 3]
This clinical trial update reports a Phase 3 study of E10A for squamous cell carcinoma of the head and neck, sponsored by Guangzhou Double B…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors [Phase 1]
Phase 1 safety study of recombinant vaccinia virus JX-594 for refractory solid tumors completed, evaluating melanoma, lung cancer, renal cel…
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: Performance of PET 18 F-FDG Coupled to CT With Contrast Injection Iodized in the Diagnosis of Early Recurrences of Head and Neck Carcinoma Treated With Concurrent Chemoradiation. Comparison With 18F-FDG PET Coupled With CT Not Injected With Filling CT Standard Injection [NA]
This completed clinical trial compared PET/CT imaging with iodinated contrast versus PET/CT without contrast for detecting early recurrences…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck [Phase 2]
Phase 2 study of AT-101 in combination with docetaxel for squamous cell carcinoma of the head and neck was terminated, with results posted i…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530) [Phase 2]
Phase 2 trial of lonafarnib in patients with recurrent squamous cell carcinoma of the head and neck has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck [Phase 1]
Phase 1 trial evaluating the combination of the TLR8 agonist VTX-2337 with cetuximab for locally advanced, recurrent, or metastatic squamous…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: Cabazitaxel - PF Induction Chemotherapy [Phase 1]
Phase 1 clinical trial update reporting completion of testing for cabazitaxel in combination with PF induction chemotherapy for squamous cel…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus [Phase 1]
Phase 1 dose-escalation study of the antibody-drug conjugate Bivatuzumab mertansine in patients with advanced squamous cell carcinoma of the…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN [Phase 2]
Phase 2 trial update investigating a gene expression signature predicting panitumumab sensitivity in untreated locally advanced squamous cel…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea
Prospective post-marketing surveillance study of cetuximab (Erbitux) in Korean patients with locally advanced, recurrent, or metastatic squa…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Zalutumumab in Non-curable Patients With SCCHN [Phase 2]
Phase 2 clinical trial update for zalutumumab in non-curable head and neck squamous cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating the addition of panitumumab to chemoradiation in locally advanced head and neck squamous cell carcinoma has complet…
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial evaluating EMD 1201081 in combination with cetuximab in second-line, cetuximab-naive recurrent or metastatic squamous cell car…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)
A completed post-marketing surveillance study evaluating cetuximab in patients with squamous cell carcinoma of the head and neck.
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN [Phase 1, Phase 2]
This clinical trial evaluated everolimus (RAD001) in combination with cetuximab and cisplatin for recurrent and metastatic head and neck can…
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) [Phase 1, Phase 2]
A Phase 1/2 trial evaluating cilengitide for recurrent and/or metastatic squamous cell carcinoma of the head and neck has completed with res…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442) [Phase 2]
Phase 2 clinical trial evaluating cetuximab with carboplatin, paclitaxel, and radiotherapy for advanced locoregional head and neck squamous …